Requirements for a biologically realistic cancer risk assessment for inorganic arsenic

International Journal of Toxicology

Volumn 18, Issue 2, 1999, Pages 131-147

  Clewell, Harvey J ^a   Robinan Gentry, P ^a   Barton, Hugh A ^a   Shipp, Annette M ^a   Yager, Janice W ^b   Andersen, Melvin E ^a  

^a ICF INTERNATIONAL   (United States)

^b ELECTRIC POWER RESEARCH INSTITUTE   (United States)

Author keywords

Arsenic; Cancer; Risk Assessment

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; COPPER; DNA; DNA POLYMERASE; DRINKING WATER; FREE RADICAL; GROWTH FACTOR; INORGANIC COMPOUND; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; WELL WATER;

CANCER RISK; CARCINOGENICITY; CELL CYCLE; CHROMATID ABERRATION; DETOXIFICATION; DNA STRAND BREAKAGE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HUMAN; LUNG CANCER; METHYLATION; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; REVIEW; RISK ASSESSMENT; SKIN CANCER; SMELTER; TUMOR SUPPRESSOR GENE; WATER CONTAMINATION;

EID: 0345059318     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225701     Document Type: Review

References (143)

1. Abernathy, C. O., W. R. Chappell, M. E. Meek, H. Gibb, and H.-R. Gho. 1996. Is ingested inorganic arsenic a "threshold" carcinogen? Fundam. Appl. Toxicol. 29:168-175.
2. Agency for Toxic Substances and Disease Registry (ATSDR). 1993. Toxicological profile for arsenic. Atlanta, GA: ATSDR.
3. Axelson, O., E. Dahlgren, C.-D. Jansson, and S. O. Rehnlund. 1978. Arsenic exposure and mortality: A case-referent study from a Swedish copper smelter. Br. J. Ind. Med. 35:8-15.
4. Barrett, J. C., P. W. Lamb, T. C. Wang, and T. C. Lee. 1989. Mechanisms of arsenic-induced cell transformation. Biol. Trace Elem. Res. 21:421-429.
5. Bates, M. N., A. H. Smith, and K. P. Cantor. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141:523-530.
6. Bates, M. N., A. H. Smith, and C. Hopenhayn-Rich. 1992. Arsenic ingestion and internal cancers: A review. Am. J. Epidemiol. 135:462-476.
7. Bohinski, R. C. 1987. Modern concepts in biochemistry. 5th ed. Boston, MA: Allyn and Bacon, Inc.
8. Borum, D. R., and C. O. Abernathy. 1994. Human oral exposure to inorganic arsenic. In Arsenic. Exposure and health, ed. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, 21-29. Northwood, UK: Science and Technology Letters.
9. Börzsönyi, M., A. Bereczky, P. Rudnai, M. Csanady, and A. Horvath. 1992. Epidemiological studies on human subjects exposed to arsenic in drinking water in Southeast Hungary. Arch. Toxicol. 66:77-78.
10. Brodeur, G., R. Seeger, M. Schwab, H. Varmus, and J. Bishop. 1984. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
11. Brown, C. C., and K. C. Chu. 1983. Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J. Nat. Cancer Inst. 70:455-463.
12. Brown, K. G., K. E. Boyle, C. W. Chen, and H. J. Gibb. 1989. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal. 9:519-528.
13. Brown, K. G., and C.-J. Chen. 1995. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Anal. 15:475-484.
14. Brown, K. G., H.-R. Guo, T.-L. Luo, and H. L. Greene. 1997. Skin cancer and inorganic arsenic: Uncertainty status of risk. Risk Anal. 17:37-42.
15. Buchet, J. P., and R. Lauwerys. 1994. Inorganic arsenic metabolism in humans. In Arsenic. Exposure and health, ed. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, 181-190. Northwood, UK: Science and Technology Letters.
16. Buchet, J. P., R. Lauwerys, P. Mahieu, and A. Geubel. 1982. Inorganic arsenic metabolism in man. Arch. Toxicol. Suppl. 5:326-327.
17. Byron, W. R., G. W. Bierbower, J. B. Brouwer, and W. H. Hansen. 1967. Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol. Appl. Pharmacol. 10:132-147.
18. Carbone, D. 1992. The p53 "knockout": gone but not forgotten. Hepatology 16:1094-1096.
19. Cebrian, M. E., A. Albores, M. Aguilar, and E. Blakely. 1983. Chronic arsenic poisoning in the north of Mexico. Human Toxicol. 2:121-133.
20. Cebrian, M. E., A. Albores, G. Garcia-Vargas, and L. M. Del Razo. 1994. Chronic arsenic poisoning in humans: The case of Mexico. In Arsenic in the environment, Part II: Human health and ecosystem effects, ed. J. O. Nriagu, 93-107. New York: John Wiley & Sons.
21. Chen, C.-J., C. W. Chen, M.-M. Wu, and T.-L. Kuo. 1992. Cancer potential in liver, lung bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66:888-892.
22. Chen, C.-J., H. Y. Chiou, M. H. Chiang, L. J. Lin, and T. Y. Tai. 1996. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 16:504-510.
23. Chen, C.-J., Y.-C. Chuang, T.-M. Lin, and H.-Y. Wu. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High arsenic artesian well water and cancers. Cancer Res. 45:5895-5899.
24. Chen, C.-J., Y.-C. Chuang, S.-L. You, T.-M. Lin, and H.-Y. Wu. 1986. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 53:399-405.
25. Chen, C.-J., Y. M. Hsueh, M. S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25:53-60.
26. Chen, C.-J., T.-L. Kuo, and M.-M. Wu. 1988a. Arsenic and cancers. Lancet, II:414-415.
27. Chen, C.-J., and L.-J. Lin. 1994. Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In Arsenic in the environment. Part II: Human health and ecosystem effects, ed. J. O. Nriagu, 109-131. New York: John Wiley & Sons.
28. Chen, C.-J., and C.-J. Wang. 1990. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 17:5470-5474.
29. Chen, C.-J., M.-M. Wu, S.-S. Lee, J.-D. Wang, S.-H. Cheng, and H.-Y. Wu. 1988b. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Arteriosclerosis 8:452-460.
30. Chiang, H.-S., C.-H. Hong, H.-R. Guo, E.-F. Lee, and T.-Y. Chen. 1988. Comparative study on the high prevalence of bladder cancer in the blackfoot disease endemic area in Taiwan. J. Formosan Med. Assoc. 87:1074-1080.
31. Chiou, H.-Y, W. I. Huang, C. L. Su, S. F. Chang, Y. H. Hsu, and C.-J. Chen. 1997. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723.
32. Chiou, H.-Y, Y.-M. Msueh, K.-F. Liaw, S.-F. Horng, M.-H. Chiang, Y.-S. Pu, J. Lin, C.-H. Huang, and C.-J. Chen. 1995. Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res. 55:1296-1300.
33. Choprapawon, C., and A. Rodcline. 1997. Chronic arsenic poisoning in Ronpibool Nakhon Sri Thammarat, the southern province of Thailand. In: Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 69-77. New York: Chapman & Hall.
34. Chowdhury, T. R., B. K. Mandal, G. Samanta, G. K. Basu, P. P. Chowdhury, C. R. Chanda, N. K. Karan, D. Lodh, R. K. Dhar, D. Das, K. C. Saha, and D. Chakraborti. 1997. Arsenic in groundwater in six districts of West Bengal, India: The biggest arsenic calamity in the world. The status report up to August, 1995. In: Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 91-111. New York: Chapman & Hall.
35. Clewell, H. J., III, D. Quinn, M. E. Andersen, and R. B. Conolly. 1995. A straightforward approximation to the exact solution of the two stage clonal growth model of cancer. Risk Anal. 95:467-473.
36. Conolly, R. B., R. H. Reitz, H. J. Clewell, and M. E. Andersen. 1988. Pharmacokinetics, biochemical mechanism and mutation accumulation: A comprehensive model of chemical carcinogenesis. Toxicol Lett. 43:189-200.
37. Cuzick, J., S. Evans, M. Gillman, and D. A. Evans. 1982. Medicinal arsenic and internal malignancies. Br. J. Cancer 45:904-911.
38. Cuzick, J., P. Sasieni, and S. Evans. 1992. Ingested arsenic, keratoses, and bladder cancer. Am. J. Epidemiol. 136:417-421.
39. Das, D., A. Chatterjee, B. K. Mandal, G. Samanta, and D. Chakraborti. 1995. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2: Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 120:917-924.
40. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221.
41. Enterline, P. E., R. Day, and G. M. Marsh. 1995. Cancers related to exposure arsenic at a copper smelter. Occup. Environ. Med. 52:28-32.
42. Enterline, P. E., and G. M. Marsh. 1982. Cancer among workers exposed to arsenic and other substances in a copper smelter. Am. J. Epidemiol. 116:895-911.
43. Enterline, P. E., V. L. Henderson, and G. M. Marsh. 1987. Exposure to arsenic and respiratory cancer. A reanalysis. Am. J. Epidemiol. 125:929-938.
44. Fan, A. M., J. P. Brown, M. A. Milea, and P. D. Spath. 1994. Arsenic in drinking water: health effects and regulatory issues in California. In Arsenic. Exposure and health, ed. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, 275-284. Northwood, UK: Science and Technology Letters.
45. Fearon, E. R., and B. Vogelstein. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
46. Flora, S. J. S., S. C. Pant, P. R. Malhotra, and G. M. Kannan. 1997. Biochemical and histopathological changes in arsenic-intoxicated rats coexposed to ethanol. Alcohol 14:563-568.
47. Gerhardsson, L., D. Brune, G. F. Nordberg, and P. O. Wester. 1988. Multielemental assay of tissues of deceased smelter workers and controls. Sci. Total Environ. 74:97-110.
48. Germolec, D. R., T. Yoshida, K. Gaido, J. L. Wilmer, P. P. Simeonova, F. Kayama, F. Burleson, W. Dong, R. W. Lange, and M. I. Luster. 1996. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141:308-318.
49. Gonsebatt, M. E., L. Vega, A. M. Salazar, R. Montero, P. Guzman, J. Blas, L. M. del Razo, M. E. Gonsebatt, L. Vega, A. M. Salazar, R. Montero, P. Guzman, J. Blas, L. M. Del Razo, G. Garcia-Vargas, A. Albores, M. E. Cebrian, M. Kelsh, and P. Ostrosky-Wegman. 1997. Cytogenic effects in human exposure to arsenic. Mutat. Res. 386:219-228.
50. Guo, H.-R., H.-S. Chiang, H. Hu, S. R. Lipsitz, and R. R. Monson. 1994. Arsenic in drinking water and urinary cancers: A preliminary report. In Arsenic. Exposure and health, ed. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, 119-124. Northwood UK: Science and Technology Letters.
51. Harvey, M., M. J. McArthur, C. A. Montgomery, Jr, J. S. Butel, A. Bradley, and L. A. Donehower. 1993. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5:225-229.
52. Hopenhayn-Rich, C., A. H. Smith, and H. M. Goeden. 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res. 60:161-177.
53. Hsueh, Y.-M., G.-S. Cheng, M.-M. Wu, H.-S. Yu, T.-L. Kuo, and C.-J. Chen. 1995. Multiple risk factors associated with arsenic-induced skin cancer: Effects of chronic liver disease and malnutritional status. Br. J. Cancer 71:109-114.
54. Huang, H., C. F. Huang, J. S. Huang, T. C. Wang, and T. C. Jan. 1992. The transition from late G1 to early S phase is most vulnerable to the coclastogenic effect of ultraviolate radiation plus arsenite. Int. J. Radiat. Biol. 61:57-62.
55. Hughes, M. F., M. Menache, and D. J. Thompson. 1994. Dose-disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol 22:80-89.
56. Ishinishi, N., Y. Kodama, K. Nobutomo, and A. Hisanaga. 1977. Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung. Environ. Health Perspect. 19:191-196.
57. Ivankovic, S., G. Eisenbrand, and R. Preussmann. 1979. Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int. J. Cancer 24:786-788.
58. Jarup, L., and G. Pershagen. 1991. Arsenic exposure, smoking, and lung cancer in smelter workers - a case-control study. Am. J. Epidemiol. 134:545-551.
59. Jarup, L., G. Pershagen, and S. Wall. 1989. Cumulative arsenic exposure and lung cancer in smelter workers: A dose-response study. Am. J. Ind. Med. 15:31-41.
60. Kanisawa M., and Schroeder HA. 1967. Life term studies on the effects of arsenic, germanium, tin, and vanadium on spontaneous tumors in mice. Cancer Res. 27:1192-1195.
61. Kanisawa, M., and H. A. Schroeder. 1969. Life term studies on the effects of trace elements on spontaneous tumors in mice and rats. Cancer Res. 29:892-895.
62. Kato K., Hayashi H., Hasegawa A., Yamanaka K., and Okada S. 1994. DNA damage induced in cultured human alveolar (L-132) cells by exposure to dimethylarsinic acid. Environ. Health Perspect. 102 (Suppl 3):285-288.
63. Kemp, C. J., L. A. Donehower, A. Bradley, and A. Balmain. 1993. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813-822.
64. Kemp, C. J., T. Wheldon, and A. Balmain. 1994. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet. 8:66-69.
65. Kempic, J. B. 1997. Arsenic removal technologies: An evaluation of cost and performance. In Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 393-405. New York: Chapman & Hall.
66. Kroes, R., M. J. van Logten, J. M. Berkvens, T. de Vries, and G. J. van Esch. 1974. Study on the carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diethylnitrosamine. Fd. Cosmet. Toxicol. 12:671-679.
67. Lai, M. S., Y. M. Hsueh, C. J. Chen, M. P. Shyu, S. Y. Chen, T. L. Kuo, M. M. Wu, and T. Y. Tai. 1992. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139:484-492.
68. Landolph, J. R. 1989. Molecular and cellular mechanisms of transformation of C3H/10T1/2 Cl 8 and diploid human fibroblasts by unique carcinogenic, nonmutagenic metal compounds. Biol. Trace. Elem. Res. 21:459-467.
69. Lavigeur, A., V. Maltby, D. Mock, J. Rossant, T. Pawson, and A. Bernstein. 1989. High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell Biol. 9:3982-3991.
70. Lee, J. M., J. L. A. Abrahamson, and A. Bernstein. 1994. DNA damage, oncogenesis and the p53 tumour-suppressor gene. Mutat. Res. 307:573-581.
71. Lee, T.-C., and I. Ho. 1994. Differential cytotoxic effects of arsenic on human and animal cells. Environ. Health Perspect 102 (Suppl 3):101-105.
72. Lee, T.-C., M. Oshimura, and J. C. Barrett. 1985. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation, and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6:1421-1426.
73. Lee, T.-C., K. Jan, and T. C. Wang. 1988. Induction of sister chromatid exchanges by arsenic in primary rat tracheal epithelial cells. Bull. Inst. Zool. Acad. Sin. 27:105-119.
74. Levine, A. J. 1992. Viruses. Scientific American Library. New York: WH Freeman and Company.
75. Li, J.-H., amd T. G. Rossman. 1989a. Inhibition of DNA ligase activity by arsenite: A possible mechanisms of its comutagenesis. Mol. Toxicol. 2:1-9.
76. Li, J.-H., and T. G. Rossman. 1989b. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol. Trace Elem Res. 21:373-381.
77. Liebscher, K., and H. Smith. 1968. Essential and nonessential trace elements: A method of determining whether an element is essential or nonessential in human tissue. Arch. Environ. Health 17:881-890.
78. Livingstone, L. R., A., White, J. Sprouse, B. A. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
79. Luo, Z. D., Y. M. Zhang, L. Ma, G. Y. Zhang, X. He, R. Wilson, D. M. Byrd, J. G. Griffiths, S. Lai, L. He, K. Grumski, and S. H. Lamm. 1997. Chronic arsenicism and cancer in Inner Mongolia - Consequences of well-water arsenic levels greater than 50 μg/l. In Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 55-68. New York: Chapman & Hall.
80. Mabuchi, K., A. M. Lilienfeld, and L. M. Snell. 1979. Lung cancer among pesticide workers exposed to inorganic arsenicals. Arch. Environ. Health 34:312-320.
81. 3: Its significance for the duration of BAL therapy. Clin. Toxicol. 18:1067-1075.
82. Mann, S., P. O. Droz, and M. Vahter. 1996a. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol. Appl. Pharmacol. 137:8-22.
83. Mann, S., P. O. Droz, and M. Vahter. 1996b. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140:471-486.
84. Marafante, E., M. Vahter, and J. Envall. 1985. The role of methylation in the detoxification of arsenate in the rabbit. Chem. Biol. Interact. 56:225-238.
85. Marin, M. C., B. Hsu, R. E. Meyn, L. A. Donehower, A. K. El-Naggar, and T. J. McDonnell. 1994. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9:3107-3112.
86. Mazumdar, S., C. K. Redmond, P. E. Enterline, G. M. Marsh, J. P. Constantino, S. Y. J. Zhou, and R. N. Patwardhan. 1989. Multistage modeling of lung cancer mortality among arsenic-exposed copper-smelter workers. Risk Anal. 9:551-563.
87. Mass, M. J., and L. Wang. 1997. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene P53 in human lung cells: A model for a mechanism of carcinogenesis. Mutat. Res. 386:263-277.
88. Menzel, D. B. 1997. Some results of a physiologically based pharmacokinetic modeling approach to estimating arsenic body burdens. In Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 349-368. New York: Chapman & Hall.
89. Milner, J. E. 1969. The effect of ingested arsenic on methylcholanthrene-induced skin tumors in mice. Arch. Environ. Health 18:7-11.
90. Moolgavkar, S. H. 1983. Model for human carcinogenesis: Action of environmental agents. Environ. Health Perspect. 50:285-291.
91. Morton, W., G. Starr, D. Pohl, J. Stoner, S. Wagner, and P. Weswig. 1976. Skin cancer and water arsenic in Lane County, Oregon. Cancer 37:2523-2532.
92. North, D. W., H. J. Gibb, and C. O. Abernathy. 1997. Arsenic: Past, present, and future considerations. In Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 406-423. New York: Chapman & Hall.
93. Nunoshiba, T., and H. Nishioka. 1987. Sodium arsenite inhibits spontaneous and induced mutations in Escherichia coli. Mutat. Res. 184:99-105.
94. Ott, M. G., B. B. Holder, and H. L. Gordon. 1974. Respiratory cancer and occupational exposure to arsenicals. Arch. Environ. Health 29:250-255.
95. Pinto S. S., P. E. Enterline, V. Henderson, and M. O. Varner. 1977. Mortality experience in relation to a measured arsenic trioxide exposure. Environ. Health Perspect. 19:127-130.
96. Rossman, T. G. 1981. Enhancement of UV-mutagenesis by the low concentrations of arsenite in E.coli. Mutat. Res. 91:207-211.
97. Rossman, T. G., E. I. Goncharova, T. Rajah, and Z. Wang. 1997. Human cells lack the inducible tolerance to arsenite seen in hamster cells. Mutat. Res. 386:307-314.
98. Rossman, T. G., D. Stone, M. Molina, and W. Troll. 1980. Absence of arsenite mutagenicity in E.coli and Chinese hamster cells. Environ. Mutagen 2:371-379.
99. Sands, A., L. A. Donehower, and A. Bradley. 1994. Gene-targeting and the p53 tumour-suppressor gene. Mutat. Res. 307:557-572.
100. 3H mice. Ann. Clin. Lab. Sci. 4:441-447.
101. Shibata, A., P. F. Ohneseit, Y. C. Tsai, C. H. Sprock, III, P. W. Nichols, H.-S. Chiang, M.-K. Lai, and P. A. Jones. 1994. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15:1085-1087.
102. Smith, A. H., C. Hopenhayn-Ricy, M. N. Bates, H. M. Goeden, I. Hertz-Picciotto, H. M. Duggan, R. Wood, M. J. Kosnett, and M. T. Smith. 1992. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97:259-267.
103. Snow, E. T. 1992. Metal carcinogenesis: Mechanistic implications. Pharmacol. Ther. 53:31-65.
104. Snow, E. T., R. S. Foote, and S. Mitra. 1984. Base-pairing properties of O6-methylguanine in template DNA during in vitro DNA replication. J. Biol. Chem. 259:8095-8100.
105. Spruck, C. H., III, P. F. Ohneseit, M. Gonzalez-Zulueta, D. Esrig, N. Miyao, Y. C. Tsai, S. P. Lerner, C. Schmutte, A. S. Yang, R. Cote, L. Dubeau, P. W. Nichols, G. G. Hermann, K. Steven, T. Horn, D. G. Skinner, and P. A. Jones. 1994. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 54:784-788.
106. Spruck, C. H., III, W. M. Rideout, III, A. F. Oloumi, P. F. Ohneseit, A. S. Yang, Y. C. Tsai, P. W. Nichols, T. Horn, G. G. Hermann, K. Steven, R. K. Rost, M. C. Yu, and P. A. Jones. 1993. Distinct pattern of p53 mutations in bladder cancer: Relationship to tobacco usage. Cancer Res. 53:1162-1166.
107. Squibb, K. S., and B. A. Fowler. 1983. The toxicity of arsenic and its compounds. In Biological and environmental effects of arsenic, ed. B. A. Fowler, 233-269. Amsterdam: Elsevier.
108. Sumino, K., K. Hayakawa, T. Shibata, and S. Kitamura. 1975. Heavy metals in normal Japanese tissues. Amounts of 15 heavy metals in 30 subjects. Arch. Environ. Health 30:487-494.
109. Symonds, H., L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Kacks, and T. VanDyke. 1994. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711.
110. Thompson, D. J. 1993. A chemical hypothesis for arsenic methylation in mammals. Chem.-Biol. Interact. 88:89-114.
111. Tseng, W. P. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
112. Tseng, C. H., C. K. Chong, J. I. Chen, and T. Y. Tai. 1996. Dose-response relationship between peripheral vascular dicease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120:125-133.
113. Tseng, W. P., H. M. Chu, S. W. How, J. M. Fong, C. S. Lin, and S. Yeh. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:453-462.
114. Tsuda, T., A. Babazono, E. Yamamoto, N. Kurumatani, Y. Mino, T. Ogawa, Y. Kishi, and H. Aoyama. 1995. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol. 141:198-209.
115. U.S. Environmental Protection Agency (USEPA). 1984. Health assessment document for inorganic arsenic. Final report. EPA 600/8-83-021F. Washington, DC: Office of Health and Environmental Assessment. March 1984.
116. U.S. Environmental Protection Agency (USEPA). 1987. Risk assessment guidelines of 1986. EPA/600/8-87/045. Washington, DC: Office of Research and Development. August 1987.
117. U.S. Environmental Protection Agency (USEPA). 1988. Special report on ingested inorganic arsenic. Skin cancer; nutritional essentiality. EPA 625/3-87-013. Washington, DC: Risk Assessment Forum. July 1988.
118. U.S. Environmental Protection Agency (USEPA). 1996. Proposed guidelines for carcinogen risk assessment. EPA/600/P-92/003C. Washington, DC: Office of Research and Development. April 1996.
119. U.S. Environmental Protection Agency (USEPA). 1998. Integrated risk information system (IRIS). Arsenic. Cincinnati, OH: National Center for Environmental Assessment.
120. U.S. Public Health Service (USPHS). 1943. Public Health Service drinking water standards. Public Health Reports 58:69-111.
121. Uthus, E. O. 1997. Mathematical modeling of arsenic in hamsters. In Arsenic. Exposure and health effects, ed. C. O. Abernathy, R. L. Calderon, and W. R. Chappell, 176-189. New York: Chapman & Hall.
122. Vahter, M. 1994. Species differences in the metabolism of arsenic. In Arsenic. Exposure and health, ed. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, 171-180. Northwood, UK: Science and Technology Letters.
123. Vahter, M., and J. Envall. 1983. In vivo reduction of arsenate in mice and rabbits. Environ. Res. 32:14-24.
124. Varmus, H, and R. A. Weinberg. 1992. Genes and the biology of cancer. New York: Scientific American Library, WH Freeman and Company.
125. Wang, Z., S. Dey, B. P. Rosen, and T. G. Rossman. 1996. Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells. Toxicol. Appl. Pharmacol. 137:112-119.
126. Wang, Z., G. Hou, and T. G. Rossman. 1994. Induction of arsenite tolerance and thermotolerance by arsenite occur by different mechanisms. Environ. Health Perspect. 102 (suppl 3):97-100.
127. Wang, Z., and T. Rossman. 1993. Stable and inducible arsenite resistance in Chinese hamster cells. Toxicol. Appl. Pharmacol. 118:80-86.
128. Wanibuchi, H., S. Yamamoto, H. Chen, K. Yoshida, G. Endo, T. Hori, and S. Fukushima. 1997. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis 17:2435-2437.
129. Warner, M. L., L. E. Moore, M. T. Smith, D. A. Kalman, E. Fanning, A. H. Smith. 1994. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol. Biomarkers Prev. 3:583-590.
130. Welch, K., I. Higgins, M. Oh, and C. Burchfiel. 1982. Arsenic exposure, smoking and respiratory cancer in copper smelter workers. Arch. Environ. Health 37:325-335.
131. Wiencke, J. K., and J. W. Yager. 1992. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ. Mol. Mutagen. 19:195-200.
132. Wiencke, J. K., J. W. Yager, A. Varkonyi, M. Hultner, and L. H. Lutze. 1997. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386:335-344.
133. Wong, O., M. D. Whorton, D. E. Foliart, and R. Lowengart. 1992. An ecologic study of skin cancer and environmental arsenic exposure. Int. Arch. Occup. Environ. Health 64:234-241.
134. Wu, M.-M., T.-L. Kuo, Y.-H. Hwang, and C.-J. Chen. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130:1123-1132.
135. Yager, J. W., and J. K. Wiencke. 1993. Enhancement of chromosomal damage by arsenic: Implications for mechanism. Environ. Health Perspect. 101 (Suppl 3):79-82.
136. Yamamoto, S., Y. Konishi, T. Matsuda, T. Murai, M.-A. Shibata, I. Matsui-Yuasa, S. Otani, K. Kuroda, G. Endo, and S. Fukushima. 1995. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55:1271-1276.
137. Yamanaka, K., K. Ohtsubo, A. Hasegawa, H. Hayashi, H. Ohji, M. Kanisawa, and S. Okada. 1996. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenic, strongly promotes tumorigenesis initiated by 4-nitroquinoline-1-oxide in the lungs of mice. Carcinogenesis 17:767-770.
138. Yamanaka, K., and S. Okada. 1994. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102 (Suppl 3):37-40.
139. Yamauchi, H., and Y. Yamamura. 1983. Concentration and chemical species of arsenic in human tissue. Bull. Environ. Contam. Toxicol. 31:267-277.
140. Yamauchi, H., and Y. Yamamura. 1985. Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology 34:113-121.
141. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
142. Yukawa, M., M. Suzuki-Yasumoto, K. Amano, and M. Terai. 1980. Distribution of trace elements in the human body determined by neutron activation analysis. Arch. Environ. Health 35:36-44.
143. Zhuang, G. S., Y. S. Wang, M. G. Tan, M. Zhi, W. Q. Pan, and Y. D. Cheng. 1990. Preliminary study of the distribution of the toxic elements As. Cd, and Hg in human hair and tissues by RNAA. Biol. Trace Elem. Res. 26-27:729-736.